- Home
- WEAV vs OCUL Comparison
WEAV vs OCUL Comparison
Compare WEAV & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEAV
- OCUL
- Stock Information
- Founded
- WEAV 2011
- OCUL 2006
- Country
- WEAV United States
- OCUL United States
- Employees
- WEAV N/A
- OCUL N/A
- Industry
- WEAV EDP Services
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- WEAV Technology
- OCUL Health Care
- Exchange
- WEAV Nasdaq
- OCUL Nasdaq
- Market Cap
- WEAV 837.7M
- OCUL 957.3M
- IPO Year
- WEAV 2021
- OCUL 2014
- Fundamental
- Price
- WEAV $9.71
- OCUL $8.46
- Analyst Decision
- WEAV Strong Buy
- OCUL Strong Buy
- Analyst Count
- WEAV 5
- OCUL 10
- Target Price
- WEAV $16.10
- OCUL $16.11
- AVG Volume (30 Days)
- WEAV 808.7K
- OCUL 1.8M
- Earning Date
- WEAV 07-30-2025
- OCUL 05-05-2025
- Dividend Yield
- WEAV N/A
- OCUL N/A
- EPS Growth
- WEAV N/A
- OCUL N/A
- EPS
- WEAV N/A
- OCUL N/A
- Revenue
- WEAV $212,950,000.00
- OCUL $59,647,000.00
- Revenue This Year
- WEAV $18.69
- OCUL N/A
- Revenue Next Year
- WEAV $15.71
- OCUL $20.05
- P/E Ratio
- WEAV N/A
- OCUL N/A
- Revenue Growth
- WEAV 19.58
- OCUL N/A
- 52 Week Low
- WEAV $8.40
- OCUL $4.79
- 52 Week High
- WEAV $17.63
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- WEAV 44.31
- OCUL 61.53
- Support Level
- WEAV $9.29
- OCUL $6.86
- Resistance Level
- WEAV $9.70
- OCUL $8.63
- Average True Range (ATR)
- WEAV 0.31
- OCUL 0.48
- MACD
- WEAV -0.03
- OCUL 0.12
- Stochastic Oscillator
- WEAV 26.25
- OCUL 90.65
About WEAV Weave Communications Inc.
Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, it enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue primarily from subscription services.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.